Disposition of the Selective Cholesterol Absorption Inhibitor Ezetimibe in Healthy Male Subjects

Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1993 • 28,274 citations

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1994 • 8,631 citations

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

1996 • 7,450 citations

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

1995 • 7,378 citations

Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels

1998 • 5,293 citations

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1998 • 5,229 citations

PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA

1995 • 3,524 citations

Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease

1994 • 1,697 citations

The Lipid Treatment Assessment Project (L-TAP)

2000 • 1,045 citations

A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results.

1997 • 543 citations

EUROASPIRE: A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results

1997 • 501 citations

Discovery of 1-(4-Fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)- hydroxypropyl]-(4S)-(4-hydroxyphenyl)-2-azetidinone (SCH 58235): A Designed, Potent, Orally Active Inhibitor of Cholesterol Absorption

1998 • 349 citations

Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663

2000 • 324 citations

In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461.

1997 • 296 citations

Noncompartmental Analysis Based on Statistical Moment Theory

1982 • 274 citations

Inadequate treatment with HMG-CoA reductase inhibitors by health care providers

1996 • 175 citations

A population pharmacokinetic model that describes multiple peaks due to enterohepatic recirculation of ezetimibe

2001 • 114 citations

Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461

1995 • 112 citations

Growth in use of statins after trials is not targeted to most appropriate patients

2000 • 47 citations

Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin

2000 • 35 citations

SCH 48461, a novel inhibitor of cholesterol absorption

1994 • 8 citations

[The effect of bile secretion on the pharmacokinetics of a theophylline sustained-release preparation].

1998 • 5 citations